我院门诊2011-2014年含丹参成分的中成药应用分析  

Analysis of the Utilization of Chinese Patent Medicines Containing Salvia miltiorrhiza in Our Hospital during 2011-2014

作　　者：朱盛[1] 冯雷[1] 王德志[1] 

机构地区：[1]中国医学科学院北京协和医院药剂科,北京100730

出　　处：《中国药房》2015年第29期4035-4037,共3页China Pharmacy

基　　金：国家临床重点专科建设项目(No.[2013]544)

摘　　要：目的:为临床合理用药提供参考。方法:统计我院2011-2014年门诊药房中含丹参成分的中成药的品种、出库数量及出库零售金额数据。采用DDDs分析方法以及Excel进行数据分类、排序及统计分析。结果:2011-2014年,我院门诊含丹参成分的中成药的销售金额变化不大,2012年较2011年下降10.52%,2013年较2012年增长8.49%,2014年与2013年基本持平。各药品的DDDs排序相对稳定,说明这些含丹参成分的中成药在近4年内使用频度较高,强度较大;各品种销售金额排序也相对稳定。结论:我院门诊含丹参成分的中成药应用基本合理,价格适中且疗效确切的中成药在临床应用中占有较大份额。OBJECTIVE：To provide reference for rational drug use in the clinic. METHODS：The calculation was carried out in type,amount and consumption sum of Chinese patent medicines containing Salvia miltiorrhiza in our hospital during 2011-2014.These data were analyzed,classified and sorted by DDDs sequence and the method of pharma-coeconomics with Excel statistically.RESULTS：The consumption sum of Chinese patent medicines containing S. miltiorrhiza took on little changes in our hospital during 2011-2014,decreasing by 10.52% in 2012 compared to 2011 but increasing by 8.49% in 2013 compared to 2012. The order of DDDs kept stable,indicating that Chinese patent medicines containing S. miltiorrhiza were used frequently in 4 year. The order of consumption sum also kept stable relatively. CONCLUSIONS：The utilization of Chinese patent medicines containing S. miltiorrhiza in our hospital is rational. Those with suitable prices and proved efficacy take a great share in the clinical application.

关 键 词：丹参 中成药 限定日剂量 用药分析 

分 类 号：R286[医药卫生—中药学] R288[医药卫生—中医学]